Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BY-NCBleeding, Thrombosis and Vascular Biology

PO038 | GLOBAL IMPLEMENTATION AND CLINICAL USE OF POINT-OF-CARE JOINT ULTRASOUND IN HEMOPHILIA: RESULTS FROM AN INTERNATIONAL SURVEY

Abstract

Background. Point-of-care joint ultrasound (POCUS) is increasingly recognized as a valuable tool in hemophilia management, enabling rapid assessment of acute joint symptoms and early identification of synovial and osteochondral changes. Despite growing evidence supporting its clinical utility, adoption remains heterogeneous worldwide, largely due to variability in training, infrastructure, and standardization. Aims. To characterize current practice patterns and unmet needs, the ISTH SSC Subcommittee conducted an international survey endorsed by EAHAD. Methods. A 38-item questionnaire was developed by an international panel of experts in musculoskeletal ultrasound and hemophilia care and distributed through the ISTH RedCap platform. The survey explored professional background, access to equipment, training, clinical applications, perceived barriers, and follow-up practices. Responses were collected globally and analyzed descriptively. Results. A total of 185 healthcare professionals from 31 countries completed the survey, including adult hematologists (21%), adult physiotherapists (19%), pediatric hematologists (17%), and pediatric physiotherapists (14%), with representation from additional disciplines. Overall, 71% of respondents reported regular use of POCUS in hemophilia care, while 29% did not routinely employ this modality. The main barriers to implementation were insufficient training or expertise (62%), limited time availability (50%), restricted funding or access to equipment (35% and 22%, respectively), lack of standardized definitions (22%), absence of reimbursement (16%), and uncertainty regarding longitudinal monitoring protocols (15%). POCUS was primarily used to confirm or exclude acute joint bleeding (71%), guide treatment duration during bleed follow-up (59%), assess synovitis (57%), support longitudinal joint surveillance (57%), evaluate painful musculoskeletal episodes (54%), and assist interventional procedures such as joint aspiration (19%). Substantial variability was observed among centers in terms of patient volumes and referral indications. Conclusions. This international survey demonstrates that POCUS is widely valued and increasingly integrated into hemophilia care, although its implementation remains inconsistent. Major limitations include insufficient structured training, limited resources, and lack of standardized protocols. Addressing these gaps through coordinated educational initiatives, harmonized definitions, and supportive health policies is essential to promote equitable, evidence-based use. These findings represent a foundation for future efforts aimed at standardizing POCUS and improving early, personalized joint management in people with hemophilia.

Related

  1. Endoscopic ultrasound-guided intratumoral alpha radiotherapy: clinical implementation of a novel therapeutic delivery platform.
    Corey S Miller, Magali Lecavalier-Barsoum, David Roberge +4
    EndoscopyPeer-reviewedCC BYFull textMedical imaging & radiologyEurope PMC
  2. PO039 | CLINICAL AND LABORATORY CHARACTERISTICS OF ACQUIRED HEMOPHILIA A: PRELIMINARY RESULTS FROM A RETROSPECTIVE OBSERVATIONAL MONOCENTRIC STUDY
    Silvia Suardi
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ
  3. Outcomes of hemophilia A in children under primary and secondary prophylaxis: results from the HEMFIL Cohort Study
    Patrícia Santos Resende Cardoso, Márcio Antônio Portugal Santana, Eder Luciano Vaz dos Santos +4
    Research and practice in thrombosis and haemostasisPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Handheld Ultrasound: Technical Review and International Expert Consensus Recommendations
    Christoph F. Dietrich, Michael Blaivas, Vito Cantisani +14
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Feasibility and perceptions among hemophilia patients and doctors towards ultrasound for the assessment of subclinical abnormalities in hemophilic joints.
    Ming Ye, Hong Zhou, Yuxin Zhao +8
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@article{fassi2026po038,
  title = {{PO038 | GLOBAL IMPLEMENTATION AND CLINICAL USE OF POINT-OF-CARE JOINT ULTRASOUND IN HEMOPHILIA: RESULTS FROM AN INTERNATIONAL SURVEY}},
  author = {Marco Fassi},
  journal = {Bleeding, Thrombosis and Vascular Biology},
  year = {2026},
  month = oct,
  url = {https://www.btvb.org/btvb/article/view/854},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - PO038 | GLOBAL IMPLEMENTATION AND CLINICAL USE OF POINT-OF-CARE JOINT ULTRASOUND IN HEMOPHILIA: RESULTS FROM AN INTERNATIONAL SURVEY
AU  - Marco Fassi
PY  - 2026
DA  - 2026/10/26
JO  - Bleeding, Thrombosis and Vascular Biology
UR  - https://www.btvb.org/btvb/article/view/854
AB  - Background. Point-of-care joint ultrasound (POCUS) is increasingly recognized as a valuable tool in hemophilia management, enabling rapid assessment of acute joint symptoms and early identification of synovial and osteochondral changes. Despite growing evidence supporting its clinical utility, adoption remains heterogeneous worldwide, largely due to variability in training, infrastructure, and standardization. Aims. To characterize current practice patterns and unmet needs, the ISTH SSC Subcommittee conducted an international survey endorsed by EAHAD. Methods. A 38-item questionnaire was developed by an international panel of experts in musculoskeletal ultrasound and hemophilia care and distributed through the ISTH RedCap platform. The survey explored professional background, access to equipment, training, clinical applications, perceived barriers, and follow-up practices. Responses were collected globally and analyzed descriptively. Results. A total of 185 healthcare professionals from 31 countries completed the survey, including adult hematologists (21%), adult physiotherapists (19%), pediatric hematologists (17%), and pediatric physiotherapists (14%), with representation from additional disciplines. Overall, 71% of respondents reported regular use of POCUS in hemophilia care, while 29% did not routinely employ this modality. The main barriers to implementation were insufficient training or expertise (62%), limited time availability (50%), restricted funding or access to equipment (35% and 22%, respectively), lack of standardized definitions (22%), absence of reimbursement (16%), and uncertainty regarding longitudinal monitoring protocols (15%). POCUS was primarily used to confirm or exclude acute joint bleeding (71%), guide treatment duration during bleed follow-up (59%), assess synovitis (57%), support longitudinal joint surveillance (57%), evaluate painful musculoskeletal episodes (54%), and assist interventional procedures such as joint aspiration (19%). Substantial variability was observed among centers in terms of patient volumes and referral indications. Conclusions. This international survey demonstrates that POCUS is widely valued and increasingly integrated into hemophilia care, although its implementation remains inconsistent. Major limitations include insufficient structured training, limited resources, and lack of standardized protocols. Addressing these gaps through coordinated educational initiatives, harmonized definitions, and supportive health policies is essential to promote equitable, evidence-based use. These findings represent a foundation for future efforts aimed at standardizing POCUS and improving early, personalized joint management in people with hemophilia.
SN  - 2785-5309
ER  -